EISSN 2148-5607

TJG IS INDEXED IN SCI-EXPANDED AND PUBMED IMPACT FACTOR: 1.4

Turkish Journal of Gastroenterology

35 414 2024

HIGHLY CITED ARTICLES

HBV and HCV are the risk factors in CCA

Tan et al.

Serum resolvin levels in irritable bowel syndrome

Karatay and Gül Utku

Microbial improvement after intervention

Qian et al.

18F-FDGPET/CT in gallbladder carcinoma

Arslan et al.

Bezoar in endoscopy

Gökbulut et al.

Effect of vitamin D on CD40L gene expression in UC

Sharifi et al.

ERCP for acute cholangitis

Khamaysi and Taha

Inborn metabolic causes of fatty liver disease

Yıldız and Sivri

Gastric and small intestinal TSA

Kiremitci et al.

COVID-19 in Hepatology and Liver transplantation

Kabaçam et al.

Submission to First Decision = 31 Days

Case Report

Kaposi’s sarcoma in patients with ulcerative colitis receiving immunosuppressive drugs: Report of a case

Bülent ÇETİN ¹ , Süleyman BÜYÜKBERBER ¹ , Işılay Bilge YILMAZ ² , Ramazan YILDIZ ¹ , Uğur COŞKUN ¹ , Mustafa BENEKLİ ³

Author Affiliation(s)

1.

Departments of Internal Medicine, Division of Medical Oncology and Pathology, Gazi University, School of Medicine, Ankara

2.

Departments of Pathology, Gazi University, School of Medicine, Ankara

3.

Hacettepe Üniversitesi Tıp Fakültesi, Gastroenteroloji Ünitesi, Ankara

Turk J Gastroenterol 2011; 22: 621-625

DOI: 10.4318/tjg.2011.0280

Keywords : Ulcerative colitis, Kaposi’s sarcoma, immunosuppression, immunomodulatory agents

Read: 1786 Downloads: 1328 Published: 25 July 2019

Volume 22, Issue 6, December 2011

Previous Article

Files